Cover Stories

  • News

    New Development of Universal Flu Vaccine

    Throughout the year WHO Centers for Reference and Research on Influenza analyze virus isolates from patients around the world and made recommendation of which circulating influenza strains will be appropriate for seasonal vaccines. Still, with all these preventive measurements, influenza epidemics continue to be a threat to the public health.

  • News

    When Lingzhi, B Cell and Globo H Meet

    The lingzhi mushroom, or referred to as reishi mushroom in Japan, has been used as a medicinal mushroom in traditional Chinese medicine for more than 2,000 years, many believe it as a regulator to human immune system as well as its potential in treating cancers.

  • News

    Milestone Check of Carbohydrate-based Vaccine Developments

    For a decade of persevere investigation, the team focusing on carbohydrate-based vaccines development led by Dr. Chi-Huey Wong and Dr. Chung-Yi Wu has been publishing exciting progress reports periodically. Their work has a core scientific concept, which is, on the surfaces of most cancerous cells or the pathogen membrane, it is bound to find uncommon sugar molecules; as long as such a sugar molecular can be identified being uniquely associated with a particular disease, and there is a way to trigger the human immune system to respond to it and produce penetrating antibodies, then, by leveraging the nature’s way, vaccines can be built by mimicking the sugar molecule to let the body fight off the disease in a much more effective way.

  • News

    Blimp-1 is a crucial gatekeeper in epidermal immunity

    Blimp-1 is a transcriptional repressor, that is, a protein which can inhibit the expression of genes; it has been demonstrated to be a significant player in the immune system.

  • News

    Collaborated Translational Research Tracks Down FUT8 in Lung Cancer

    With a persistent quest and clever collaborations, digging clue after clue, a team in Dr. Chi-Huey Wong’s research group has identified the role of FUT8, an enzyme which adds sugar molecules to proteins; their study showed FUT8 matters a LOT in human nonsmall cell lung cancer (NSCLC).

  • News

    Location Matters

    DNA methylation is already a known key factor that attributes to the gene expression, namely, its presence has a direct correlation between regarding gene being “turned on” or not, therefore, it has become quite a marker for epigenetic study.

  • News

    A Breakthrough in Carbohydrate-Based Vaccine: One Vaccine Targets Three Unique glycan Epitopes on Cancer Cells and Cancer Stem Cells

    A cure for breast cancer may be in sight! The GRC research team has been studying carbohydrate antigens on the surface of cancer cells and cancer stem cells for years. Lately, a published paper on PNAS reports their new finding of some special carbohydrates.

  • News

    Strike on the Drug Resistance Problems of Influenza Infections

    Tamiflu, an orally available drug targeting influenza neuraminidase, has been used widely in clinics for treating influenza virus infections. Over the years of usage, influenza viruses have developed resistance over Tamiflu.

  • News

    Negatively Charged Gold Nanoparticles Proved to Ease the Accumulation of Proteins Causing Alzheimer’s Disease

    A new gold rush in the biotech world has been underway, studies of  gold particles in nano scales have been applied to researches from cancer treatments to bio-imaging technologies. Now, a collaborated study led by Dr. Ruby Chen may have just added another possible application to this precious metal that we humans treasure from way back.

  • News

    A Brave New Way to Tackle the Hepatitis C Viral Problem

    By pushing the boundaries and thinking out of the box, Dr. Tien-Hsien Chang demonstrates once again what a scientific spirit is all about.

  • News

    Lin’s Lab Unravels the Pathway of Plasma Cells

    There are millions variations of B cells, and when a certain type of B cells are called on duty, their mission is to make specific plasma cells, which act as sole purpose factories focusing on making a specific type of antibodies.